Summary
Many neuropeptides and peptide hormones are remarkably similar to antimicrobial peptides in their amino acid composition, amphipathic design, cationic charge, and size.
Their antimicrobial activity suggests they have a direct role in innate defense. In this review we explore the possibility that the mammalian nervous system, equipped with peptides that exhibit potent antimicrobial properties, utilize neurotransmitters and hormones, in certain settings to directly defend the organism from microbial assault. We focus on several anatomical settings in man in which certain neuropeptides, known to play a critical role in local physiological functioning, could provide a previously unrecognized direct anti-infective, innate immune role in the skin, the gingival crevice of the mouth, the olfactory epithelium, and the adrenal gland.
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Considerable evidence has mounted to support active communication between the nervous system and the immune system. The nervous system, including the brain and the peripheral divisions can either stimulate or inhibit various activities of both the innate and adaptive immune systems. Conversely, the immune system, through the release of cytokines, can influence the activity of the nervous system. Several excellent reviews have addressed the subjects of nervous and immune system "cross-talk" in great detail [1] [2] [3] .
Very recently, however, several peptides, recognized initially for their neural or neuroendocrine signaling functions have been shown to exhibit potent antimicrobial activity. This discovery signals the possibility that the nervous system, through utilization of these peptides, has the capacity to deliver antinfective agents directly to innervated sites, localized with great spatial specificity and delivered rapidly. The nervous and neuroendocrine systems, in principle, have the potential serve a direct immune function.
The skin of most species of frog contains specialized neuro-epithelial structures called granular glands. These structures synthesize and store high concentrations of fully processed, active, antimicrobial peptides (directed at microbes), neuropeptides and neuromuscular toxins (directed at macro-predators). The glands are innervated by adrenergic nerves, which, when stimulated, result in the discharge of the contents of the gland onto the surface of the animal's skin 4 . A dramatic demonstration of this effect can be seen minutes after exposure of an adult African clawed frog (Xenopus laevis) to pharmacological doses of noradrenalin, resulting in the massive, simultaneous discharge of all functional granular glands on the skin (Fig. 1) . In this example, the nervous system is invested with the capacity to directly defend the epithelium of this animal by 4 discharging a specialized epithelial structure, delivering a potent, highly concentrated cocktail of antimicrobial peptides onto the surface 5 .
Clearly, for defensive purposes, frogs use the capacity of the nervous system to respond rapidly to noxious stimuli, and to focus its response at specific sites on the skin surface. In this review we explore the possibility that the mammalian nervous system, equipped with peptides that exhibit potent antimicrobial properties, utilizes these neurotransmitters and hormones, in certain settings, like the example of Xenopus, to directly defend the organism from microbial assault.
The blurring definition of antimicrobial peptides, chemokines, and growth factors
Antimicrobial peptides are integral components of innate defense against microbial infection and disease (See article by Selsted, et al in this issue). Over 818 different peptides with antimicrobial activity 6 are produced in many tissues and cell types by a variety of animal, plant, and invertebrate species [7] [8] [9] [10] .
Antimicrobial peptides were initially discovered as a consequence of their antiinfective activity. However, several antimicrobial peptides have subsequently been
shown to exhibit additional biological activities beneficial in the setting of tissue injury and infection (Fig. 2) Other biological effects of mammalian antimicrobial peptides include stimulation of angiogenesis (Fig. 2) , induction of epithelial growth factor receptors and coreceptors 14 and stimulation of epithelial division [15] [16] [17] .
With the discovery that defensins shared receptor binding properties with certain immune cell cytokines, the antimicrobial activity of known cytokines were explored and subsequently discovered. Thus, MIP3α exhibits a more potent antimicrobial activity than HBD2 ; CXCL9,-10, and -11, interferon γ inducible chemokines are active against E.coli 
Making sense of "neuropeptides" with antimicrobial properties
Antimicrobial peptides of multicellular organisms are amphipathic, membrane active molecules that interact with the membranes of a wide spectrum of microbe. Similarly, neuropeptides are generally amphipathic molecules, a property that permits them to achieve high local concentrations within the aqueous space between nerve ending and receptor, and, at the same time, high local concentrations within their target membrane 22 .
Indeed, this shared property of amphipathicity served as the motivation behind recent reports of the antimicrobial activities of well studied neuropeptides. Antimicrobial activity, per se, does not alone support the presumed anti-infection function of a peptide.
The effective local concentrations achieved must be compatible with the potency, an issue often difficult to evaluate given the paucity of data regarding actual concentrations 7 of a peptide in situ, and the meaningfulness of antimicrobial activity as measured under the artificial setting of an in vitro assay. Nevertheless, we wish to focus on several anatomical settings in man in which certain neuropeptides, known to play a critical role in local physiological functioning, could provide a previously unrecognized direct antiinfective, innate immune role. The sites we wish to highlight are the skin, the gingival crevice of the mouth, the olfactory epithelium and the adrenal gland.
Substance P
Substance P (SP) is widely distributed throughout the peripheral and central nervous systems. SP is present in a subpopulation of sensory neurons with unmyelinated axons, C-type fibers, which transmit pain ("nocioceptive" stimuli: chemical irritants, injury, heat/cold) from the skin (Fig. 2) . These fibers have sensory receptors that transmit impulses toward dorsal ganglia, acting as classical afferent nerves; in addition, these same thin fibers can also function as efferent nerves, by releasing release peptides from the same nerve endings that received the noxious stimuli 23 . In the skin SP induces rounding of endothelial cells, relaxation of vascular smooth muscle, leading to capillary leakage and vasodilatation, chemotaxis of neutrophils and macrophages, proliferation of keratinocytes and fibroblasts, mast cell degranulation, and induction of expression of various adhesion proteins on local endothelial, epithelial, and inflammatory cells 24 . SP induces these responses by direct interaction with the NK1 receptor on its target cells, and is deficient in NK1 knock out mice 25 , or when effectively blocked by specific antagonists 26 . In addition, the duration of action of an SP stimulus and the extent of its "geographic" impact is constrained by the presence of "neutral endopeptidase", a 8 protease generally expressed in the local tissue vicinity of SP containing nerve endings 27 .
Thus, following a noxious stimulus SP can rapidly set into motion a timed, stereotypically orchestrated defensive scenario even in the absence of actual cellular injury ( Fig. 2) .
SP has been shown in vitro to exhibit antimicrobial activity against S. aureus, E.
coli, E. faecalis, P. vulgaris, Ps. aeruginosa, and C. albicans 28 . The relative potency is comparable to a potent bactericidal neutrophil antimicrobial peptide indolicidin. The mechanism of antimicrobial activity is not known, but the distribution of amino acids predicts a cationic amphipathic secondary structure comparable to other antimicrobial peptides and likely operating via a common mechanism.
Thus, temporally, the first consequence of the discharge of SP from its nerve endings would be the local infusion of a broad spectrum antimicrobial agent into the tissue space between the nerve endings and the cells bearing NK1 receptors, to be followed by the "slower" unfolding of the NK1-receptor dependent components of the ensuing inflammatory response (Fig. 2) . . Full thickness wounds take a significantly longer period of time to heal in the db/db animals than wild type litter mates, and SP applied to the wounds speeds the healing process in the diabetic animals.
The oral mucosal epithelium has been shown to express defensins, as well as salivary gland histatins, lactoferrin, lysozyme and other proteins with antimicrobial properties 32 . As in other epithelial sites, structures in the oral cavity, including the epithelial surfaces of the oropharyngeal chamber and the tongue, certain microbes and certain cytokines ( such as IL-1β) have been shown to stimulate expression of inducible antimicrobial defensins, such as HBD-2. A particularly 'hostile" area of the oral cavity is the region between the tooth enamel surface and the gingival surface -the junctional epithelium (JE) -a physical crevice in which food and microbes can accumulate out of the reach of the abrasive action of the tongue and natural flow of saliva (Fig. 3) . The JE is a non-keratinized epithelium with a rapid cellular turnover. It is normally infiltrated with neutrophils, even in the absence of inflammation, suggesting these cells accumulate as normal residents of this tissue. The neutrophil based antimicrobial peptides, HNP1
and LL-37 can be localized to the JE and can found in gingival crevicular fluid 33 (Fig. 3) .
Surprisingly, unlike the lingual surfaces of the gingival epithelium and most sites in the oral cavity, the JE itself does not exhibit induction of the inducible antimicrobial peptides, HBD-2 or LL-37, suggesting a dependence on alternative modes of antimicrobial defense. The JE is intensely vascularized with a plexus of venules, and richly innervated with SP containing nerve fibers (Fig. 3 ) 34 . The epithelial cells, vasculature and neutrophils express the NK1 SP receptor. It has been suggested that these SP releasing neurons maintain the "resident" neutrophil population in the JE, via tonic stimulation 34 . A genetic disorder involving the maturation of myeloid tissues, "Morbus Kostmann" in which the concentration of LL-37 in circulating neutrophils is profoundly depressed, is associated with severe periodontal disease, caused by the commensal microbe. A. actinomycetemcomitans suggesting the importance of the neutrophil antimicrobial peptide expression in control of microbial flora in the JE 35 .
NPY
Neuropeptide tyrosine (NPY) is a 36 amino acids peptide widely distributed throughout the central and peripheral nervous system 36 . Within the brain NPY is expressed in circuits that affect diverse processes such as feeding, behavior, and energy balance 37, 38 .
Within the peripheral nervous system, NPY is especially concentrated within the NPY is also synthesized by certain non-neuronal cells of the nervous system 39,40 .
In particular, NPY is expressed by a class of glial cells that lie within the olfactory epithelium called olfactory ensheathing cells (OEC) (Fig. 4) . OEC are a specialized class of glial cells that accompany olfactory sensory neurons as they extend axonal processes from the epithelium through the skull (via the perforated bone called the cribiform plate)
ultimately synapsing with nerve endings within the olfactory bulb of the brain. The olfactory epithelium lies at the roof of the nasal chamber of the pharynx. It is exposed to all microbes inhaled through the nose, and provides microbes an anatomical route via the perforated cribiform plate a direct route of entry to the brain. In addition, within the olfactory epithelium are neuronal stem cells, which differentiate continuously throughout life into the olfactory sensory neurons 41 . The olfactory ensheathing cells, which lie immediately beneath the superficial epithelial layer (sustentacular cells) envelop the olfactory neuronal axons, and are believed to both guide the axons and prevent diverting interactions with neural tissue as the axons attempt connection with targets in the olfactory bulb 42 . NPY, secreted by the OECs is believed to act as a growth factor for the olfactory neuron based on in vitro evidence of stimulatory activity and reduced density of olfactory neurons in NPY knockout mice 41 .
Precisely what protects the olfactory epithelium from continuous infection, chronic inflammation, and facile microbial entry into the brain remains unexplained although several newly described proteins related to known antimicrobial proteins have been discovered to be expressed in the olfactory epithelium, such as the RY/PLUNC proteins 43, 44 , close relatives of the neutrophil bactericidal protein, BPI 45 ; these proteins are also secreted by Bowman's glands, a structure which bathes the surface of the olfactory epithelium with a specialized secretion). The recent discovery that NPY has direct antimicrobial activity might also provide a partial explanation for the general "health" of the olfactory tissue. In vitro, NPY was shown to exhibit potent antifungal activity against C. albicans, Cryptococcus neoformans, and Arthroderma simii and likely activity against Gram negative and Gram positive microbes based on sequence similarity to the homologous potent broad spectrum antimicrobial peptide SPYY, isolated from the skin of the frog, Phylomedusa bicolor 46 . The mechanism of action of NPY appears to be similar to other cationic amphiphilic alpha-helical antimicrobial peptides, based on the effects of specific amino acid substitutions on its anti-microbial potency 36 . The expression of NPY by non-neuronal cells within the sustentacular layer, as well as by the olfactory ensheathing cells, might secrete a local "antimicrobial barrier" protecting the projecting axons, discouraging microbial invasion along the axonal tract, and suppressing a need for the assistance of tissue destructive inflammatory cells in the clearance of microbes (Fig 4) .
Adrenomedullin
AM is a 52 amino acid peptide with a single disulphide bridge, isolated in 1993 from a pheochromocytoma 47 ; it is processed proteolytically from a precursor which also contains a second biologically active 20 residue peptide, PAMP, located on the N-terminus of the precursor. Systemic administration of AM or PAMP to mammals, including man, produces vasodilatation resulting in depression of systemic blood pressure through both 13 direct interaction with specific receptors on the peripheral vasculature as well as with sites within the CNS involved in the regulation of blood pressure 48 . AM is expressed in a wide variety of tissues, but a surprising and unexplained variation in the sets of tissues expressing AM mRNA is observed between species 49 . In humans AM immunoreactivity is found in many diverse tissues including the skin, specific sites within the brain, heart muscle, vascular smooth muscle and endothelium, adrenal medulla, kidney tubular epithelium, and the lumenal mucosal surface and glandular epithelium of the digestive, reproductive and respiratory tracts, as well as in neuroendocrine and endocrine tissues, such as pancreatic islet cells 50 . AM shares a G protein coupled receptor with calcitoningene related peptide (CGRP); specificity for either peptide is imparted by the association of a accessory protein, RAMP, of which 3 genes have been identified, RAMPS 1,2, and 3. Association of RAMPS 2 and 3 with the CGRP receptor confers specificity for ADM, while RAMP1 confers CGRP specificity; specific patterns of tissue expression of each of the RAMP genes are observed 51, 52 .
AM expression in many tissues is strongly induced by the presence of microbes, LPS, or pro-inflammatory cytokines, such as IL-1, as demonstrated both in vitro, and following administration of LPS in vivo [53] [54] [55] . With respect to LPS stimulation TLR4 appears to be involved in the stimulation of AM expression in macrophages, since AM expression in cells from C3H/HJ mice following LPS exposure is not observed 53 . It has been suggested that AM might represent a principal mediator of systemic hypotension observed in the setting of bacterial sepsis, prompting the consideration of AM receptor antagonists as potential therapies for this condition 53 .
Very recently, both AM and its partner peptide, PAMP, have been shown to exhibit potent microbicidal activity against a wide range of Gram positive and Gramnegative bacteria [56] [57] [58] [59] . Commensal and pathogenic organisms that characteristically inhabit specific sites on the human body are killed by concentrations of AM in the 0.5-25 ug/ml range, likely within the range of AM concentrations expressed on the exposed surfaces of the epithelia from these areas. The data strongly suggest that AM has the capacity to provide the sites of expression with broad spectrum, inducible, antimicrobial protection 50, 60, 61 . The potent activity of both PAMP and AM against organisms such as P. gingivalis and P. acnes suggests a role for this molecule in control of growth of these microbes in the gingival crevice of the mouth and the skin, respectively. Indeed, AM can be recovered from the gingival crevice at mg/ml concentrations, well above the minimal bactericidal concentration measured in vitro 62 . In the setting of skin infection and or injury, release of AM from the epidermis would be predicted to stimulate proliferation of keratinocytes, fibroblasts, and produce local vasodilatation (and increased blood flow) through interaction with AM receptors present on these cells and structures 63 (Fig. 2) . In contrast to both the inducible epithelial defensins and cathelicidins, which are expressed in the more differentiated layers of the epidermis and accumulate within the stratum corneum, AM is present in the most basal layers as well, including the stem cell layer 60, 61 ( Fig. 1) . This would suggest that AM is designed to provide antimicrobial protection to 65 . Indeed, systemic administration of αMSH or synthetic analogues exhibit activity in animal models of local and systemic inflammation, including rheumatoid arthritis, inflammatory bowel disease, encephalitis, and experimental autoimmune uveitis [66] [67] [68] . These effects are mediated, in part, through interaction of αMSH with MC receptors on cells involved in the inflammatory response. αMSH suppresses TNF-α production by activated monocytes and reduces expression of CD86, a costimulatory molecule; αMSH inhibits neutrophil chemotaxis and inhibits the production of pro-inflammatory cytokines from many types of human cell following stimulation by lipopolysaccharide ; αMSH inhibits the LPS-induced activation of VCAM-1 and E selectin in human microvascular cells 68 . A universal mechanism involving MSH inhibition of NFkB stimulation has been postulated to underlie its broad anti-inflammatory property 69, 70 .
Current views of the properties of αMSH in human skin are informative. Levels of receptor are low in normal keratinocytes. UV radiation, or pro-inflammatory cytokines such as IL-1, stimulate the keratinocyte's and melanocyte's production of both αMSH and the MCR1 receptor [71] [72] [73] . Hence, in human skin, αMSH appears to exert its antiinflammatory effects following pro-inflammatory or injurious stimuli. αMSH stimulates human epidermal melanocytes to take on a dendritic shape, required for transfer of pigment to keratinocytes. αMSH stimulates eumelanin (dark brown) synthesis more robustly than it does the yellow-reddish pigment, pheomelanin; eumelanin is more photoprotective for cellular DNA against UV radiation than pheomelanin, and accumulates in "eumelanosomes" which organize in the melanocytes and keratinocytes in "sun-protective"supranuclear caps (Fig. 2) .
Recent studies have demonstrated that αMSH has potent anti-microbial activity 64, 74 . Although activity against S. aureus was demonstrated, the activity against
Candida albicans was more extensively studied with respect to mechanism. In the case of The precise role played by the antimicrobial peptides that can be generated within the adrenal medulla remains uncertain, but PEA and chromogranin concentrations are sufficiently high for us to entertain the possibility that antimicrobial peptides generated from these proteins might serve to provide local antimicrobial protection within the adrenal medulla itself, following activation of the sympathetic nervous system, or release of LPS into the intravascular space. The loss of the adrenal gland secondary to infection, is a lethal medical crisis associated with shock. However, except in the setting of meningococcemia, infection or inflammation of the adrenal gland is a medical rarity.
The non-inflammatory mechanisms that defend the adrenal gland from blood borne microbes remain unknown.
Concluding Remarks
The inclusion of neuropeptides into the armentarium of antimicrobial peptides extends the known mechanisms by which the nervous system can influence immune function. 
